Andre Moura is Managing Director of New Mountain Capital. He previously worked at McKinsey. He currently serves as Chairman or lead director of Aceto, Gelest, ILC Dover and Topix Pharmaceuticals. He also serves as a director of Alteon Health, Avantor, Bellerophon and Sparta Systems. He previously served as a director of ACA Compliance Group, Medical Specialties Distributors and NuSil.
He received his A.B., magna cum laude, in Computer Science from Harvard College and his M.B.A., with high distinction, from Harvard Business School in 2009, where he was a Baker Scholar.
Sophia Banay Moura is a digital content strategist and award-winning editor and writer. She graduated from Harvard College.